These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2687857)

  • 21. Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report.
    Smith T; Sharp S; Manzardo AM; Butler MG
    Int J Mol Sci; 2015 Feb; 16(3):4416-28. PubMed ID: 25710722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochromes: a primer for child and adolescent psychiatrists.
    Oesterheld JR; Shader RI
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):447-50. PubMed ID: 9549967
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine.
    Crettol S; de Leon J; Hiemke C; Eap CB
    Clin Pharmacol Ther; 2014 Mar; 95(3):254-7. PubMed ID: 24196844
    [No Abstract]   [Full Text] [Related]  

  • 24. [Xenobiotic-metabolizing polymorphic enzymes. An opportunity for individualized drug treatment].
    Lhermitte M; Allorge D; Broly F
    Bull Acad Natl Med; 2006 Jan; 190(1):55-69; discussion 69-73. PubMed ID: 16878446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs.
    Athanasiu L; Smorr LL; Tesli M; Røssberg JI; Sønderby IE; Spigset O; Djurovic S; Andreassen OA
    J Psychopharmacol; 2015 Aug; 29(8):884-91. PubMed ID: 25944848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics of psychotropic drug response.
    Malhotra AK; Murphy GM; Kennedy JL
    Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics and psychoactive drug therapy: ready for the patient?
    Steimer W
    Ther Drug Monit; 2010 Aug; 32(4):381-6. PubMed ID: 20526233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of psychotropic drugs in special populations.
    Rudorfer MV
    J Clin Psychiatry; 1993 Sep; 54 Suppl():50-4; discussion 55-6. PubMed ID: 8407858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relation between mexidol glucuronide conjugation and characteristics of its therapeutic effect in patients with organic lesions in the central nervous system].
    Sariev AK; Davydova IA; Neznamov GG; Zherdev VP; Teleshova ES
    Eksp Klin Farmakol; 2001; 64(3):17-21. PubMed ID: 11558431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
    Stingl JC; Bartels H; Viviani R; Lehmann ML; Brockmöller J
    Pharmacol Ther; 2014 Jan; 141(1):92-116. PubMed ID: 24076267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Status of and perspectives on psychiatric genomic medicine].
    Mors NP; Børglum AD
    Ugeskr Laeger; 2005 May; 167(20):2191-3. PubMed ID: 15987082
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacogenomics and therapeutic strategies for dementia.
    Cacabelos R
    Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetics of psychoactive drugs.
    Nurnberger JI
    J Psychiatr Res; 1987; 21(4):499-505. PubMed ID: 2831355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized medicine in psychiatry: new technologies and approaches.
    Costa e Silva JA
    Metabolism; 2013 Jan; 62 Suppl 1():S40-4. PubMed ID: 23018148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalized pharmacotherapy in psychiatry.
    Filaković P; Petek A
    Psychiatr Danub; 2009 Sep; 21(3):341-6. PubMed ID: 19794353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin transporter gene promotor polymorphism (5-HTTLPR) associations with number of psychotropic medication trials in a tertiary care outpatient psychiatric consultation practice.
    Rundell JR; Staab JP; Shinozaki G; McAlpine D
    Psychosomatics; 2011; 52(2):147-53. PubMed ID: 21397107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs.
    Bertilsson L; Dahl ML; Dalén P; Al-Shurbaji A
    Br J Clin Pharmacol; 2002 Feb; 53(2):111-22. PubMed ID: 11851634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of psychotropic drugs: pharmacological and clinical relevance.
    Daniel W
    Pol J Pharmacol; 1995; 47(5):367-79. PubMed ID: 8868127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
    Kanner AM; Gidal BE
    Int Rev Neurobiol; 2008; 83():397-416. PubMed ID: 18929094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs.
    Eap CB
    Dialogues Clin Neurosci; 2016 Sep; 18(3):313-322. PubMed ID: 27757065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.